Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Arrakis37on Mar 20, 2018 11:48am
143 Views
Post# 27746763

RE:Dedicated to the FUD pumpers pushing sp & cash worries

RE:Dedicated to the FUD pumpers pushing sp & cash worriesI think your argument is useless to convince people who do not want to be convinced. I totally agree with your reading of the situation but unfortunately and ironically, all those who are long have no power over the price of the stock (since they keep their positions), and there's not enough new serious buyers. The action remains at this level and is handled by few people. But as you said, that does not mean anything in the long run.

This company has innovated tremendously, had incredible clinical results and is now much too important to be a failure. They are getting stronger and probably have the best financial strategists to help them. By the way I've never seen so much hate for a potential so high.  imho
Bullboard Posts